Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol.
Ilse A C SpiekmanBirgit S GeurtsLaurien J ZeverijnGijs F de WitVincent van den NoortPaul RoepmanWendy W J de LengAnne M L JansenBenno KustersLaurens V BeerepootFilip Yves Francine De VosDerk-Jan A de GrootJan Willem B de GrootAnn HoebenJan ButerAndré B P van KuilenburgEmile E VoestHenk M W VerheulPublished in: The oncologist (2023)
Panitumumab treatment provides limited CB in patients with recurrent RAF/RASwt glioblastoma precluding further development of this therapeutic strategy.
Keyphrases